ABI, Thermo Fisher Scientific, Invitrogen, Bruker, Sigma-Aldrich, Proteome Sciences, Cellzome, Theranostics Health, NIH, Kinaxo Biotechnologies, Takeda, Battelle Pacific Northwest National Laboratory, Promega, GeneCopoeia, GeneGo, Chinese University of Ho | GenomeWeb
ABI MS Growth Continues to Slow, Total Revs up 4.3 Percent for Q3
Applied Biosystems reported growth of less than 1 percent in its mass spectrometry business this week, while overall revenues rose 4.3 percent for its fiscal third quarter.
For the three months ended March 31, ABI’s mass spec revenues rose to $128.5 million, up .94 percent from $127.3 million a year ago. The percentage of total revenues from mass spec sales decreased to 23 percent from 24 percent a year ago.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.